Document is current
Any future updates will be listed below
-
Authors
Rösche, Johannes
Wittstock, Matthias
Shah, Yogesh
- License Information
-
More Information
Article History
Accepted: 26 August 2024
First Online: 25 September 2024
Declarations
:
: J. Rösche received a speakerʼs honorarium from EISAI. M. Wittstock reports personal fees from Astra Zeneca, which are outside the submitted work. Y. Shah received speaker’s fees from Boehringer Ingelheim, Bayer, Daiichi Sankyo, Bristol-Myers Squibb and Pfizer concerning novel anticoagulants in the past 5 years and also reimbursement for travel expenses from Boehringer Ingelheim and Daiichi Sankyo.
: For this article no studies with human participants or animals were performed by any of the authors. All studies mentioned were in accordance with the ethical standards indicated in each case.
